Laboratory research material only. Not for human or animal consumption.
Retatrutide 20mg research peptide vial · Polaris Research

Weight & Metabolism · 20mg

Retatrutide 20mg

CAS 2381089-83-2

$259

Or 4 payments of $64.75 with Afterpay. Zip and Klarna are also available at checkout.

Sourced to order, dispatched within 7 days
1

Bulk savings

Applied automatically at checkout

The more vials in your order, the less each one costs. No code needed.

  • 2 vials5%
  • 3 vials10%
  • 4 vials15%
  • 5 vials20%
  • 6 vials25%
  • 7+ vials30%

Peptide vials only. Bacteriostatic water is an add-on and stays at list price.

#1 in monthly peptide rankings
Free Express Delivery, No Minimum
Quality Certificate Included
Save 2% with PayID / Osko
Save 5% to 30% on 2+ Vials
Sealed Under Argon
Sourced to Order · Ships in 7 Days

The Retatrutide 20mg vial (Reta, or the Reta peptide) is the larger format of the triple-agonist research peptide studied across the GLP-1, GIP, and glucagon receptor pathways at once. It holds double the material of the 10mg vial in a single lyophilised unit, which is why it is the format most researchers reach for when a longer investigation block would otherwise mean reordering. Same compound, same CAS reference (2381089-83-2), better per-milligram value.Retatrutide is studied in preclinical and in-vitro models for how simultaneous engagement of three metabolic receptors influences appetite signalling, glucose-handling models, and body-composition pathways. Reaching all three receptors is what distinguishes it from the single-agonist (GLP-1 only) and dual-agonist compounds that came before it, and it is that combined receptor profile, rather than any one pathway, that drives the current research interest.The 20mg format is the value choice for sustained work: the per-milligram cost is lower than buying two 10mg vials, and a single vial covers more reference aliquots before a reorder is needed. Researchers comparing receptor profiles across compounds may find our retatrutide versus tirzepatide library guide useful, and those wanting a smaller first reference batch can start with the Retatrutide 10mg vial.Every 20mg vial ships lyophilised with an independently verified batch certificate at a guaranteed floor of ≥98% purity, which you can confirm on the batch verification page using the batch number on the label. Reconstitute with bacteriostatic water: add it slowly down the wall of the vial, swirl to dissolve, and never shake. Store unopened at 2 to 8°C; refrigerate the reconstituted solution and do not refreeze it.Buying retatrutide in Australia is domestic and direct: free Australia Post Express shipping Australia-wide with no minimum spend, dispatch from within Australia within two business days of confirmed payment (most within 24 hours), and tracking on every parcel. Pay by card, PayPal, or PayID; every vial is sealed under argon with a 24-hour payment reservation on your stock. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.

Formal Name
Retatrutide
CAS Number
2381089-83-2
Purity
99.6% · batch-tested
Description
Larger-format retatrutide vial for longer metabolic research blocks involving GLP-1, GIP and glucagon receptor signalling.
Research Focus
Metabolic research, appetite signalling, body-composition pathways and glucose-handling models.
Suggested Use
Reference plan: 2 mg aliquots on a once-weekly research cadence. Use the larger vial where a longer protocol has already been planned.
Doses per Vial
10 x 2 mg reference aliquots.
Concentration
2 mg per reference aliquot from a 20 mg vial.
Notes
Investigational compound; document tolerability observations carefully before any protocol change.
Monthly Ranking

#1 most popular research peptide

View ranking

Retatrutide carries 189 indexed publications, 34 registered trials, 6 with Australian sites, 39,578 monthly readers on Wikipedia. Research activity sits at 84 papers in the past twelve months against 58 the year before.

Why It's Searched

High-intent searches for GLP-1, GIP, and glucagon-pathway research peptides.

Evidence Standing

189 papers, 84 this year · 34 trials, 6 in Australia · 39,578 readers (-29%) · S tier

buy retatrutide australiaretatrutide cost australiaretatrutide australiaretatrutide peptide
Updated 3 September 2026

Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.

Independent Research
Evidence Overview on reptides.co

Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.

Pairs Well With

Complete your order

Related Reading

From the library

Other Quantities

Other formats & sizes

Also Searched As·Retatrutide is also searched as Reta peptide, Reta, R3ta peptide, Reda peptide, Ratatouille peptide, Retatrude, Retatutide, Retaturide, Retaturiride, LY3437943, LY-3437943, Retatrutide peptide, Triple agonist peptide, Skinny jab, Triple G peptide.

Research File

What has been published on Retatrutide

Accelerating

Retatrutide appears in 204 indexed publications going back to 2022, including 94 in the past twelve months. 34 registered trials appear on ClinicalTrials.gov, 6 with Australian sites.

204
Indexed publications
94
Past 12 months
34 (6 AU)
Registered trials
35,065
Monthly readers, down 11%
20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20150
20160
20170
20180
20190
20200
20210
20222
202316
202441
202558
202687
Read the full Retatrutide research fileCounts from Europe PMC and ClinicalTrials.gov, refreshed weekly. Reported as a record of what exists, not as evidence of any effect.